 | • レポートコード：QFJ1-3835 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、抗リウマチ薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（非ステロイド性抗炎症薬、ステロイド性抗炎症薬、遅効性薬、免疫学的準備）、用途別市場規模（製薬業、病院＆診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・抗リウマチ薬の市場動向 ・企業の競争状況、市場シェア ・抗リウマチ薬の種類別市場規模と予測2016-2027（非ステロイド性抗炎症薬、ステロイド性抗炎症薬、遅効性薬、免疫学的準備） ・抗リウマチ薬の用途別市場規模と予測2016-2027（製薬業、病院＆診療所、その他） ・抗リウマチ薬の北米市場規模2016-2027（アメリカ、カナダ） ・抗リウマチ薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・抗リウマチ薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・抗リウマチ薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・抗リウマチ薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AbbVie、Amgen、Pfizer、Roche Holding AG、Novartis International AG、Johnson & Johnson、Bristol-Myers Squibb、Merck、UCB S.A.、Eli Lilly and Company） ・結論 |
Antirheumatics Pharmaceutical refers to drugs that can treat rheumatism, such as non-steroidal anti-inflammatory drugs, steroidal anti-inflammatory drugs, etc.
Market Analysis and Insights: Global Antirheumatics Pharmaceutical Market
The global Antirheumatics Pharmaceutical market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Antirheumatics Pharmaceutical market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Antirheumatics Pharmaceutical market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Antirheumatics Pharmaceutical market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Antirheumatics Pharmaceutical market.
Global Antirheumatics Pharmaceutical Scope and Market Size
Antirheumatics Pharmaceutical market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Antirheumatics Pharmaceutical market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Non-Steroidal Anti-Inflammatory Drugs
Steroidal Anti-Inflammatory Drugs
Slow Acting Drug
Immunological Preparation
Segment by Application
Pharmaceutical Industry
Hospital and Clinic
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
AbbVie
Amgen
Pfizer
Roche Holding AG
Novartis International AG
Johnson & Johnson
Bristol-Myers Squibb
Merck
UCB S.A.
Eli Lilly and Company
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antirheumatics Pharmaceutical Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Non-Steroidal Anti-Inflammatory Drugs
1.2.3 Steroidal Anti-Inflammatory Drugs
1.2.4 Slow Acting Drug
1.2.5 Immunological Preparation
1.3 Market by Application
1.3.1 Global Antirheumatics Pharmaceutical Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pharmaceutical Industry
1.3.3 Hospital and Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Antirheumatics Pharmaceutical Market Perspective (2016-2027)
2.2 Antirheumatics Pharmaceutical Growth Trends by Regions
2.2.1 Antirheumatics Pharmaceutical Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Antirheumatics Pharmaceutical Historic Market Share by Regions (2016-2021)
2.2.3 Antirheumatics Pharmaceutical Forecasted Market Size by Regions (2022-2027)
2.3 Antirheumatics Pharmaceutical Industry Dynamic
2.3.1 Antirheumatics Pharmaceutical Market Trends
2.3.2 Antirheumatics Pharmaceutical Market Drivers
2.3.3 Antirheumatics Pharmaceutical Market Challenges
2.3.4 Antirheumatics Pharmaceutical Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antirheumatics Pharmaceutical Players by Revenue
3.1.1 Global Top Antirheumatics Pharmaceutical Players by Revenue (2016-2021)
3.1.2 Global Antirheumatics Pharmaceutical Revenue Market Share by Players (2016-2021)
3.2 Global Antirheumatics Pharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Antirheumatics Pharmaceutical Revenue
3.4 Global Antirheumatics Pharmaceutical Market Concentration Ratio
3.4.1 Global Antirheumatics Pharmaceutical Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antirheumatics Pharmaceutical Revenue in 2020
3.5 Antirheumatics Pharmaceutical Key Players Head office and Area Served
3.6 Key Players Antirheumatics Pharmaceutical Product Solution and Service
3.7 Date of Enter into Antirheumatics Pharmaceutical Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antirheumatics Pharmaceutical Breakdown Data by Type
4.1 Global Antirheumatics Pharmaceutical Historic Market Size by Type (2016-2021)
4.2 Global Antirheumatics Pharmaceutical Forecasted Market Size by Type (2022-2027)
5 Antirheumatics Pharmaceutical Breakdown Data by Application
5.1 Global Antirheumatics Pharmaceutical Historic Market Size by Application (2016-2021)
5.2 Global Antirheumatics Pharmaceutical Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Antirheumatics Pharmaceutical Market Size (2016-2027)
6.2 North America Antirheumatics Pharmaceutical Market Size by Type
6.2.1 North America Antirheumatics Pharmaceutical Market Size by Type (2016-2021)
6.2.2 North America Antirheumatics Pharmaceutical Market Size by Type (2022-2027)
6.2.3 North America Antirheumatics Pharmaceutical Market Size by Type (2016-2027)
6.3 North America Antirheumatics Pharmaceutical Market Size by Application
6.3.1 North America Antirheumatics Pharmaceutical Market Size by Application (2016-2021)
6.3.2 North America Antirheumatics Pharmaceutical Market Size by Application (2022-2027)
6.3.3 North America Antirheumatics Pharmaceutical Market Size by Application (2016-2027)
6.4 North America Antirheumatics Pharmaceutical Market Size by Country
6.4.1 North America Antirheumatics Pharmaceutical Market Size by Country (2016-2021)
6.4.2 North America Antirheumatics Pharmaceutical Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Antirheumatics Pharmaceutical Market Size (2016-2027)
7.2 Europe Antirheumatics Pharmaceutical Market Size by Type
7.2.1 Europe Antirheumatics Pharmaceutical Market Size by Type (2016-2021)
7.2.2 Europe Antirheumatics Pharmaceutical Market Size by Type (2022-2027)
7.2.3 Europe Antirheumatics Pharmaceutical Market Size by Type (2016-2027)
7.3 Europe Antirheumatics Pharmaceutical Market Size by Application
7.3.1 Europe Antirheumatics Pharmaceutical Market Size by Application (2016-2021)
7.3.2 Europe Antirheumatics Pharmaceutical Market Size by Application (2022-2027)
7.3.3 Europe Antirheumatics Pharmaceutical Market Size by Application (2016-2027)
7.4 Europe Antirheumatics Pharmaceutical Market Size by Country
7.4.1 Europe Antirheumatics Pharmaceutical Market Size by Country (2016-2021)
7.4.2 Europe Antirheumatics Pharmaceutical Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Antirheumatics Pharmaceutical Market Size (2016-2027)
8.2 Asia-Pacific Antirheumatics Pharmaceutical Market Size by Type
8.2.1 Asia-Pacific Antirheumatics Pharmaceutical Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Antirheumatics Pharmaceutical Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Antirheumatics Pharmaceutical Market Size by Type (2016-2027)
8.3 Asia-Pacific Antirheumatics Pharmaceutical Market Size by Application
8.3.1 Asia-Pacific Antirheumatics Pharmaceutical Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Antirheumatics Pharmaceutical Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Antirheumatics Pharmaceutical Market Size by Application (2016-2027)
8.4 Asia-Pacific Antirheumatics Pharmaceutical Market Size by Region
8.4.1 Asia-Pacific Antirheumatics Pharmaceutical Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Antirheumatics Pharmaceutical Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Antirheumatics Pharmaceutical Market Size (2016-2027)
9.2 Latin America Antirheumatics Pharmaceutical Market Size by Type
9.2.1 Latin America Antirheumatics Pharmaceutical Market Size by Type (2016-2021)
9.2.2 Latin America Antirheumatics Pharmaceutical Market Size by Type (2022-2027)
9.2.3 Latin America Antirheumatics Pharmaceutical Market Size by Type (2016-2027)
9.3 Latin America Antirheumatics Pharmaceutical Market Size by Application
9.3.1 Latin America Antirheumatics Pharmaceutical Market Size by Application (2016-2021)
9.3.2 Latin America Antirheumatics Pharmaceutical Market Size by Application (2022-2027)
9.3.3 Latin America Antirheumatics Pharmaceutical Market Size by Application (2016-2027)
9.4 Latin America Antirheumatics Pharmaceutical Market Size by Country
9.4.1 Latin America Antirheumatics Pharmaceutical Market Size by Country (2016-2021)
9.4.2 Latin America Antirheumatics Pharmaceutical Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antirheumatics Pharmaceutical Market Size (2016-2027)
10.2 Middle East & Africa Antirheumatics Pharmaceutical Market Size by Type
10.2.1 Middle East & Africa Antirheumatics Pharmaceutical Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Antirheumatics Pharmaceutical Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Antirheumatics Pharmaceutical Market Size by Type (2016-2027)
10.3 Middle East & Africa Antirheumatics Pharmaceutical Market Size by Application
10.3.1 Middle East & Africa Antirheumatics Pharmaceutical Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Antirheumatics Pharmaceutical Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Antirheumatics Pharmaceutical Market Size by Application (2016-2027)
10.4 Middle East & Africa Antirheumatics Pharmaceutical Market Size by Country
10.4.1 Middle East & Africa Antirheumatics Pharmaceutical Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Antirheumatics Pharmaceutical Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Antirheumatics Pharmaceutical Introduction
11.1.4 AbbVie Revenue in Antirheumatics Pharmaceutical Business (2016-2021)
11.1.5 AbbVie Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Antirheumatics Pharmaceutical Introduction
11.2.4 Amgen Revenue in Antirheumatics Pharmaceutical Business (2016-2021)
11.2.5 Amgen Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Antirheumatics Pharmaceutical Introduction
11.3.4 Pfizer Revenue in Antirheumatics Pharmaceutical Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Roche Holding AG
11.4.1 Roche Holding AG Company Details
11.4.2 Roche Holding AG Business Overview
11.4.3 Roche Holding AG Antirheumatics Pharmaceutical Introduction
11.4.4 Roche Holding AG Revenue in Antirheumatics Pharmaceutical Business (2016-2021)
11.4.5 Roche Holding AG Recent Development
11.5 Novartis International AG
11.5.1 Novartis International AG Company Details
11.5.2 Novartis International AG Business Overview
11.5.3 Novartis International AG Antirheumatics Pharmaceutical Introduction
11.5.4 Novartis International AG Revenue in Antirheumatics Pharmaceutical Business (2016-2021)
11.5.5 Novartis International AG Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Antirheumatics Pharmaceutical Introduction
11.6.4 Johnson & Johnson Revenue in Antirheumatics Pharmaceutical Business (2016-2021)
11.6.5 Johnson & Johnson Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Details
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb Antirheumatics Pharmaceutical Introduction
11.7.4 Bristol-Myers Squibb Revenue in Antirheumatics Pharmaceutical Business (2016-2021)
11.7.5 Bristol-Myers Squibb Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Antirheumatics Pharmaceutical Introduction
11.8.4 Merck Revenue in Antirheumatics Pharmaceutical Business (2016-2021)
11.8.5 Merck Recent Development
11.9 UCB S.A.
11.9.1 UCB S.A. Company Details
11.9.2 UCB S.A. Business Overview
11.9.3 UCB S.A. Antirheumatics Pharmaceutical Introduction
11.9.4 UCB S.A. Revenue in Antirheumatics Pharmaceutical Business (2016-2021)
11.9.5 UCB S.A. Recent Development
11.10 Eli Lilly and Company
11.10.1 Eli Lilly and Company Company Details
11.10.2 Eli Lilly and Company Business Overview
11.10.3 Eli Lilly and Company Antirheumatics Pharmaceutical Introduction
11.10.4 Eli Lilly and Company Revenue in Antirheumatics Pharmaceutical Business (2016-2021)
11.10.5 Eli Lilly and Company Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Antirheumatics Pharmaceutical Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Non-Steroidal Anti-Inflammatory Drugs
Table 3. Key Players of Steroidal Anti-Inflammatory Drugs
Table 4. Key Players of Slow Acting Drug
Table 5. Key Players of Immunological Preparation
Table 6. Global Antirheumatics Pharmaceutical Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Antirheumatics Pharmaceutical Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Antirheumatics Pharmaceutical Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Antirheumatics Pharmaceutical Market Share by Regions (2016-2021)
Table 10. Global Antirheumatics Pharmaceutical Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Antirheumatics Pharmaceutical Market Share by Regions (2022-2027)
Table 12. Antirheumatics Pharmaceutical Market Trends
Table 13. Antirheumatics Pharmaceutical Market Drivers
Table 14. Antirheumatics Pharmaceutical Market Challenges
Table 15. Antirheumatics Pharmaceutical Market Restraints
Table 16. Global Antirheumatics Pharmaceutical Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Antirheumatics Pharmaceutical Market Share by Players (2016-2021)
Table 18. Global Top Antirheumatics Pharmaceutical Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antirheumatics Pharmaceutical as of 2020)
Table 19. Ranking of Global Top Antirheumatics Pharmaceutical Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Antirheumatics Pharmaceutical Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Antirheumatics Pharmaceutical Product Solution and Service
Table 23. Date of Enter into Antirheumatics Pharmaceutical Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Antirheumatics Pharmaceutical Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Antirheumatics Pharmaceutical Revenue Market Share by Type (2016-2021)
Table 27. Global Antirheumatics Pharmaceutical Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Antirheumatics Pharmaceutical Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Antirheumatics Pharmaceutical Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Antirheumatics Pharmaceutical Revenue Market Share by Application (2016-2021)
Table 31. Global Antirheumatics Pharmaceutical Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Antirheumatics Pharmaceutical Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Antirheumatics Pharmaceutical Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Antirheumatics Pharmaceutical Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Antirheumatics Pharmaceutical Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Antirheumatics Pharmaceutical Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Antirheumatics Pharmaceutical Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Antirheumatics Pharmaceutical Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Antirheumatics Pharmaceutical Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Antirheumatics Pharmaceutical Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Antirheumatics Pharmaceutical Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Antirheumatics Pharmaceutical Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Antirheumatics Pharmaceutical Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Antirheumatics Pharmaceutical Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Antirheumatics Pharmaceutical Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Antirheumatics Pharmaceutical Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Antirheumatics Pharmaceutical Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Antirheumatics Pharmaceutical Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Antirheumatics Pharmaceutical Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Antirheumatics Pharmaceutical Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Antirheumatics Pharmaceutical Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Antirheumatics Pharmaceutical Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Antirheumatics Pharmaceutical Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Antirheumatics Pharmaceutical Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Antirheumatics Pharmaceutical Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Antirheumatics Pharmaceutical Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Antirheumatics Pharmaceutical Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Antirheumatics Pharmaceutical Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Antirheumatics Pharmaceutical Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Antirheumatics Pharmaceutical Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Antirheumatics Pharmaceutical Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Antirheumatics Pharmaceutical Market Size by Country (2022-2027) & (US$ Million)
Table 63. AbbVie Company Details
Table 64. AbbVie Business Overview
Table 65. AbbVie Antirheumatics Pharmaceutical Product
Table 66. AbbVie Revenue in Antirheumatics Pharmaceutical Business (2016-2021) & (US$ Million)
Table 67. AbbVie Recent Development
Table 68. Amgen Company Details
Table 69. Amgen Business Overview
Table 70. Amgen Antirheumatics Pharmaceutical Product
Table 71. Amgen Revenue in Antirheumatics Pharmaceutical Business (2016-2021) & (US$ Million)
Table 72. Amgen Recent Development
Table 73. Pfizer Company Details
Table 74. Pfizer Business Overview
Table 75. Pfizer Antirheumatics Pharmaceutical Product
Table 76. Pfizer Revenue in Antirheumatics Pharmaceutical Business (2016-2021) & (US$ Million)
Table 77. Pfizer Recent Development
Table 78. Roche Holding AG Company Details
Table 79. Roche Holding AG Business Overview
Table 80. Roche Holding AG Antirheumatics Pharmaceutical Product
Table 81. Roche Holding AG Revenue in Antirheumatics Pharmaceutical Business (2016-2021) & (US$ Million)
Table 82. Roche Holding AG Recent Development
Table 83. Novartis International AG Company Details
Table 84. Novartis International AG Business Overview
Table 85. Novartis International AG Antirheumatics Pharmaceutical Product
Table 86. Novartis International AG Revenue in Antirheumatics Pharmaceutical Business (2016-2021) & (US$ Million)
Table 87. Novartis International AG Recent Development
Table 88. Johnson & Johnson Company Details
Table 89. Johnson & Johnson Business Overview
Table 90. Johnson & Johnson Antirheumatics Pharmaceutical Product
Table 91. Johnson & Johnson Revenue in Antirheumatics Pharmaceutical Business (2016-2021) & (US$ Million)
Table 92. Johnson & Johnson Recent Development
Table 93. Bristol-Myers Squibb Company Details
Table 94. Bristol-Myers Squibb Business Overview
Table 95. Bristol-Myers Squibb Antirheumatics Pharmaceutical Product
Table 96. Bristol-Myers Squibb Revenue in Antirheumatics Pharmaceutical Business (2016-2021) & (US$ Million)
Table 97. Bristol-Myers Squibb Recent Development
Table 98. Merck Company Details
Table 99. Merck Business Overview
Table 100. Merck Revenue in Antirheumatics Pharmaceutical Business (2016-2021) & (US$ Million)
Table 101. Merck Recent Development
Table 102. UCB S.A. Company Details
Table 103. UCB S.A. Business Overview
Table 104. UCB S.A. Antirheumatics Pharmaceutical Product
Table 105. UCB S.A. Revenue in Antirheumatics Pharmaceutical Business (2016-2021) & (US$ Million)
Table 106. UCB S.A. Recent Development
Table 107. Eli Lilly and Company Company Details
Table 108. Eli Lilly and Company Business Overview
Table 109. Eli Lilly and Company Antirheumatics Pharmaceutical Product
Table 110. Eli Lilly and Company Revenue in Antirheumatics Pharmaceutical Business (2016-2021) & (US$ Million)
Table 111. Eli Lilly and Company Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antirheumatics Pharmaceutical Market Share by Type: 2020 VS 2027
Figure 2. Non-Steroidal Anti-Inflammatory Drugs Features
Figure 3. Steroidal Anti-Inflammatory Drugs Features
Figure 4. Slow Acting Drug Features
Figure 5. Immunological Preparation Features
Figure 6. Global Antirheumatics Pharmaceutical Market Share by Application: 2020 VS 2027
Figure 7. Pharmaceutical Industry Case Studies
Figure 8. Hospital and Clinic Case Studies
Figure 9. Other Case Studies
Figure 10. Antirheumatics Pharmaceutical Report Years Considered
Figure 11. Global Antirheumatics Pharmaceutical Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Antirheumatics Pharmaceutical Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Antirheumatics Pharmaceutical Market Share by Regions: 2020 VS 2027
Figure 14. Global Antirheumatics Pharmaceutical Market Share by Regions (2022-2027)
Figure 15. Global Antirheumatics Pharmaceutical Market Share by Players in 2020
Figure 16. Global Top Antirheumatics Pharmaceutical Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antirheumatics Pharmaceutical as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Antirheumatics Pharmaceutical Revenue in 2020
Figure 18. Global Antirheumatics Pharmaceutical Revenue Market Share by Type (2016-2021)
Figure 19. Global Antirheumatics Pharmaceutical Revenue Market Share by Type (2022-2027)
Figure 20. North America Antirheumatics Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Antirheumatics Pharmaceutical Market Share by Type (2016-2027)
Figure 22. North America Antirheumatics Pharmaceutical Market Share by Application (2016-2027)
Figure 23. North America Antirheumatics Pharmaceutical Market Share by Country (2016-2027)
Figure 24. United States Antirheumatics Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Antirheumatics Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Antirheumatics Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Antirheumatics Pharmaceutical Market Share by Type (2016-2027)
Figure 28. Europe Antirheumatics Pharmaceutical Market Share by Application (2016-2027)
Figure 29. Europe Antirheumatics Pharmaceutical Market Share by Country (2016-2027)
Figure 30. Germany Antirheumatics Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Antirheumatics Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Antirheumatics Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Antirheumatics Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Antirheumatics Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Antirheumatics Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Antirheumatics Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Antirheumatics Pharmaceutical Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Antirheumatics Pharmaceutical Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Antirheumatics Pharmaceutical Market Share by Region (2016-2027)
Figure 40. China Antirheumatics Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Antirheumatics Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Antirheumatics Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Antirheumatics Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Antirheumatics Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Antirheumatics Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Antirheumatics Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Antirheumatics Pharmaceutical Market Share by Type (2016-2027)
Figure 48. Latin America Antirheumatics Pharmaceutical Market Share by Application (2016-2027)
Figure 49. Latin America Antirheumatics Pharmaceutical Market Share by Country (2016-2027)
Figure 50. Mexico Antirheumatics Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Antirheumatics Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Antirheumatics Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Antirheumatics Pharmaceutical Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Antirheumatics Pharmaceutical Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Antirheumatics Pharmaceutical Market Share by Country (2016-2027)
Figure 56. Turkey Antirheumatics Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Antirheumatics Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Antirheumatics Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. AbbVie Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2016-2021)
Figure 60. Amgen Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2016-2021)
Figure 62. Roche Holding AG Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2016-2021)
Figure 63. Novartis International AG Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2016-2021)
Figure 64. Johnson & Johnson Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2016-2021)
Figure 65. Bristol-Myers Squibb Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2016-2021)
Figure 66. Merck Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2016-2021)
Figure 67. UCB S.A. Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2016-2021)
Figure 68. Eli Lilly and Company Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
世界の非ステロイド性抗炎症薬（NSAID）市場規模・現状・予測（2021年-2027年） Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and ki…- 世界の抗炎症薬市場規模・現状・予測（2021年-2027年） Antiinflammatory Drugs are drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Market Analysis and Insights: Global Antiinflammatory Drugs Market The global Antiinflammatory Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020…
- 世界の抗喘息薬＆COPD薬市場規模・現状・予測（2021年-2027年） The anti-asthmatics and chronic obstructive pulmonary disease (COPD) market consists of sales of anti-asthmatics and chronic obstructive pulmonary disease (COPD) drugs which are used to relieve the frequency of acute attacks of asthma, emphysema, chronic bronchitis, and nocturnal awakenings. The cla…
- 世界の抗パーキンソン薬市場規模・現状・予測（2021年-2027年） Anti-Parkinson Drugs are drugs used to treat Parkinson's disease. The most commonly used Anti-Parkinson Drugs act on the dopaminergic system of the striatum and basal ganglia, or are central muscarinic antagonists. Market Analysis and Insights: Global Anti-Parkinson Drugs Market The global Anti-Park…
- 世界のインスリン非依存型糖尿病治療薬市場規模・現状・予測（2021年-2027年） Diabetes is a metabolic disease, wherein the body is either unable to secret insulin (type 1 diabetes) or is unable to utilize the generated insulin (type 2 diabetes). Market Analysis and Insights: Global Non Insulin Anti diabetes Drugs Market The global Non Insulin Anti diabetes Drugs market size i…